Overview
A growing pharma marketing company, established in February 2023, is now available for sale. Operating from a fully equipped 200 sq. ft. rented office cum warehouse, the company deals in a diverse product range including tablets, capsules, injectables, syrups, and ointments. It leverages contract manufacturing through two reputed manufacturers, ensuring quality and scalability. The business serves 30 to 40 hospital clients, indicating strong market reach and consistent demand. The company operates on a hybrid business model encompassing five proprietary formulations, two franchisees, and trading activities. With a first-year turnover of ₹59 lakh and a robust profit margin of 20%, the company presents an excellent opportunity for investors or existing players looking to expand in the pharmaceutical sector.
Leased Trading Business Pharma Trading
Business Details
2022
Year of Establishment
2
No. of Employees
Running Profitable
Current Status of Business
YesBusiness Relocatable
LeasedProperty Type
8.3 Thousand Rental per Month
Describe Property
N.A
Competition / Market
MARKET IS HAVING HUGE POTENTIALITY AND UNIQUE BUSINESS MODEL OF GOVT SUPPLY,DISPENSORS AND PRIDSCRIPTION BASE DIVERSIFY THE RISK OF COMPETITION .
Products & Services
SUPPLY ALL TYPES OF CRITICAL CARE INJECTABLES AND MEDICINE TO GOVT HOSPITALS UNDER QUOATATION AND LOCAL PURCHASE,PCD FRANCHISE OF GENERAL BRANDS,5 OWN THIRD PARTYB PRODUCTS,DISPENSER AND PRISCRIBER BASE.
Growth Potential
OPPORTUNITIES FOR GROWTH AND EXPANSION DRIVEN BY INCREASING DEMAND FOR PHARMACEUTICALS PRODUCTS,EXPAND THE BUSINESS BY EMPROVING OPERATIONS AND EXPLORING NEW MARKETS.
Reason For Sale
SHIFTING PUNE
Financial Details
EBITDA :-
2
PAT :-
1
Debt :-
20
How the Acquisition Process Works
- 01Contact SellerContact Seller
- 02Teaser/Information MemorandumTeaser/Information Memorandum
- 03Valuation ReportValuation Report
- 04FinancialsFinancials
- 05Schedule an Advisory MeetingBook Your Consultation